| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director | Director, 10% Owner
3 companies
Canaan IX L.P. last filed a Form 4 in October 2020, as 10% Owner at REAL. The filings on record cover 3 companies. From October 2015 to October 2020, the filings on record show 0 open-market purchases and 15 sales.
At the last filing, the largest reported position was 7,925,919 shares of REAL.
Shares as reported in the last Form 4 for each company; the most recent is from October 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 22,463 | $10.75 | $241,477.25 | -0.5% | |
| May 27, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 25,082 | $10.60 | $265,869.20 | -0.6% | |
| May 26, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 51,343 | $10.34 | $530,810.53 | -1.1% | |
| May 24, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 13,253 | $10.09 | $133,735.30 | -0.3% | |
| May 20, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 8,687 | $10.10 | $87,776.83 | -0.2% |